Nomic Bio
Nomic Bio, formerly known as nplex biosciences, is a healthcare diagnostics company based in Montreal, Canada, with a team of 24. It specializes in high-throughput protein profiling through its nELISA platform and has raised $17M in Series A funding.
Company Overview
Nomic Bio, previously known as nplex biosciences, operates in the healthcare sector with a focus on diagnostics. The company is headquartered in Montreal, QC, Canada, and also has a location in Somerville, Massachusetts, USA. With a team size of 24, this partly remote organization serves regions primarily in Canada and America.
Y-Combinator and Funding
Nomic Bio participated in the Winter 2020 batch of Y-Combinator, a well-known startup accelerator. The company successfully raised $17 million in Series A funding, which has supported its continued growth and innovation in the diagnostics industry.
nELISA Platform
Nomic Bio developed the nELISA platform, a cutting-edge solution for high-throughput protein profiling. This platform addresses the cross-reactivity problem typically encountered in multiplexed immunoassays, enabling the study of protein expression, interaction, or modification on a single platform. The nELISA platform achieves multiplexing at scale without compromising on quality, providing broad profiling and absolute quantification with an exquisite precision of less than 5% CV day-to-day.
Services
Nomic Bio offers diagnostic services with a fast turnaround time, often as quick as one week. The company focuses on delivering high-quality results swiftly, benefiting clients in their research and development endeavors. Their platform allows for unparalleled cost efficiency in protein profiling, making advanced diagnostics more accessible.
Locations
Nomic Bio maintains offices in Montreal, QC, Canada, and Somerville, Massachusetts, USA. These strategic locations enable the company to serve a diverse clientele across North America efficiently, while also leveraging the benefits of remote and partly remote operations.